What Vikor Scientific does

Vanta Diagnostics, formerly Vikor Scientific, is a US-based molecular diagnostics company founded in 2018 that provides rapid pathogen detection, semi-quantification, and antibiotic resistance gene identification to healthcare providers. The company operates three CAP-accredited and CLIA-certified laboratories in Charleston SC, Blue Bell PA, and Tampa FL, serving physicians, diagnostic laboratories, and health systems across multiple clinical specialties including dermatology, gastroenterology, orthopedics, wound care, respiratory infections, STIs, and surgical infections. Its core platform delivers results in less than 24 hours from specimen arrival and is organized into 10+ branded proprietary test panels (Derm-ID, Gastro-ID, Joint-ID, Nail-Fungal-ID, Respira-ID, STI-ID, Surgical-ID, Urine-ID, Vaginal-ID, Wound-ID), supplemented by Antibiotic Resistance Testing, Pharmacogenetics, and Covid-19 testing.

The company's business model is B2B sales-led, targeting healthcare providers through dedicated provider portals, sales portals, and online ordering and pickup request systems. Revenue is generated through diagnostic laboratory services under negotiated contracts with healthcare providers and health plans, with pricing not publicly disclosed. A distinguishing service layer is the PharmD Guidance program, which embeds clinical pharmacist consultation into the test workflow to advise providers on treatment plans based on pathogen results, resistance genes, published sensitivity patterns, medication costs, antibiotic spectrum, and FDA guidance — supporting antibiotic stewardship and value-based care.

In late 2025, the company rebranded from Vikor Scientific to Vanta Diagnostics and was affected by a third-party vendor data breach at revenue cycle management provider Catalyst RCM, which exposed protected health information of 139,964 individuals across Vanta Diagnostics and affiliated laboratory companies KorGene (a wholly-owned subsidiary) and KorPath (an affiliated pathology lab partner). The rebrand signals a strategic repositioning around antibiotic stewardship and value-based medicine in infectious disease treatment.

Name

Vikor Scientific

Legal name

Vanta Diagnostics

Website

https://vikorscientific.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

251–500 employees

Short description

Vanta Diagnostics (formerly Vikor Scientific) is a US molecular diagnostics company operating CAP/CLIA-certified labs in SC, PA, and FL, providing rapid pathogen detection and antibiotic resistance gene testing to healthcare providers across multiple clinical specialties via branded test panels and PharmD clinical consult services.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Infectious Disease POCT (Respiratory, STI, HIV, Sepsis) (HLAHAOAA)

Keywords

• Molecular diagnostics services
• Pathogen detection testing
• Antibiotic resistance testing
• Infectious disease diagnostics
• Antibiotic stewardship testing

Headquarters

HQ city

Charleston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Diagnostic Laboratory Services: Laboratory testing services for pathogen detection and antibiotic resistance identification. The company provides molecular diagnostic tests to healthcare providers with results delivered within 24 hours.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Vikor Scientific (now Vanta Diagnostics) provides rapid molecular diagnostic testing services for pathogen detection, semi-quantification, and antibiotic resistance gene identification, delivered through a proprietary panel portfolio covering respiratory, gastrointestinal, wound, dermatological, joint, nail fungal, STI, surgical, urinary, and vaginal infections. Tests are processed at CAP/CLIA-certified laboratories and return results within 24 hours of specimen arrival, complemented by PharmD clinical decision guidance to support antibiotic stewardship for healthcare providers.

Product overview

Vanta Diagnostics (formerly Vikor Scientific) is a molecular diagnostics company offering rapid molecular pathogen detection through a platform of targeted diagnostic tests. The product portfolio includes multiple molecular testing panels organized by body site or infection type (Respira-ID for respiratory, Gastro-ID for gastrointestinal, Wound-ID for wounds, Derm-ID for dermatological, Joint-ID for joints, Nail-Fungal-ID, STI-ID, Surgical-ID, Urine-ID, Vaginal-ID), plus Antibiotic Resistance Testing and Pharmacogenetics. All tests provide pathogen identification and resistance gene detection in under 24 hours. The company complements its diagnostic testing with PharmD Guidance—a clinical pharmacist consultation service that assists healthcare providers in selecting optimal treatment regimens based on test results, sensitivity patterns, medication costs, and FDA guidance, enabling value-based, patient-centered care in infectious disease treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibiotic Resistance Testing

Quantifiable outcome

• Results delivered in less than 24 hours from specimen arrival at the lab

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor.

• Catalyst RCMminorOthers · 13 November 2025Revenue cycle management vendor that stored and managed data on behalf of Vikor Scientific (Vanta Diagnostics), KorGene, and KorPath. Unauthorized server access occurred between November 8-9, 2025, resulting in a data breach affecting 139,964 individuals. Catalyst RCM was made aware of suspicious activity on November 13, 2025. This was not a strategic partnership but rather a vendor relationship that resulted in a security incident.
• KorPathminorOthersTampa-based anatomical pathology laboratory that was an affiliated company alongside KorGene, sharing data with the compromised Catalyst RCM vendor. The Everest ransomware group claimed to have stolen data from KorPath along with Vikor Scientific and KorGene. KorPath operates from the Tampa, FL laboratory location (CAP # 2743001 / CLIA #10D0699501).
• KorGeneminorOthersAffiliated diagnostic laboratory company that shared data with the compromised Catalyst RCM vendor. KorGene was impacted alongside Vikor Scientific (Vanta Diagnostics) and KorPath in the data breach affecting 139,964 individuals.

Scale indicators1 record

Recent moves8 records

Expansion highlights5 records

Direct peers

• BioFire Diagnostics (bioMérieux): BioFire is the direct molecular syndromic diagnostics leader (FilmArray panels) and the most direct competitor to Vanta's multi-panel pathogen detection strategy across respiratory, GI, and other infectious disease indications.
• Cepheid (Danaher): Cepheid's GeneXpert system is a leading molecular diagnostics platform with extensive infectious disease and antimicrobial resistance menus, competing directly with Vanta's rapid molecular pathogen and resistance gene tests.

Emerging players

• Accelerate Diagnostics: Accelerate specializes in rapid identification and antimicrobial susceptibility testing for serious infections, directly overlapping Vanta's resistance-gene and antibiotic stewardship value proposition.
• T2 Biosystems: T2 Biosystems develops rapid molecular diagnostics for sepsis and other infectious diseases, representing an emerging competitor focused on rapid pathogen detection where Vanta also competes.
• Genetic Signatures: Genetic Signatures develops 3base molecular diagnostics for infectious disease detection, representing a smaller specialty competitor with overlapping technology and clinical applications.
• Molbio Diagnostics: Molbio's Truenat and Truelab point-of-care molecular platforms target infectious disease testing globally, representing an emerging competitor in the rapid molecular pathogen detection category.

Broad incumbents

• Quest Diagnostics: Quest is a national reference laboratory offering a broad molecular and infectious disease test menu, providing scale advantages and payor contracts that compete with Vanta's specialty panels in the same provider market.
• Laboratory Corporation of America (Labcorp): Labcorp operates one of the largest US clinical lab networks with extensive molecular diagnostics capabilities and serves the same healthcare provider customers as Vanta.
• Becton, Dickinson and Company (BD): BD's Diagnostic Systems segment includes the BD MAX molecular platform and a broad infectious disease assay portfolio, positioning BD as a scaled incumbent in the same molecular pathogen detection category as Vanta.
• Hologic: Hologic's Panther and other molecular systems serve women's health, STI, and infectious disease testing, with overlapping offerings to Vanta's STI-ID and Vaginal-ID panels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vanta-diagnostics
• Xx.com/scientificvikor

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vikor Scientific